Gastroenterology Unit, Department of Medicine, B. R. Singh Hospital, Kolkata, India.
Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Gut Liver. 2024 Jul 15;18(4):578-592. doi: 10.5009/gnl230396. Epub 2024 Apr 29.
Disorders of the gut-brain interaction (DGBIs) are presently classified into mutually exclusive anatomical area-related symptom-based categories according to the Rome IV criteria. The pathophysiology of visceral nociception, which contributes to the wide range of symptoms of DGBIs, involves complex psychobiological processes arising from the bidirectional interactions of multiple systems at the gut and brain levels, which affect symptom expression and illness behaviors. The attitude toward an illness and expression of pain and bowel habit vary across cultures with variable interpretation based on sociocultural beliefs, which may not tally with the medical definitions. Thus, psychological factors impact DGBI definitions, their severity and health care utilization. Due to the poor localization and multisegment referral of visceral pain, the anatomical site of pain may not correspond to the affected segment, and there may be a variable degree of overlap among symptoms. The somewhat restrictively defined Rome IV criteria assume one-to-one correlation of symptoms with underlying pathophysiology and ignore overlapping DGBIs, nonstandardized symptom categories, and change or shift in category over time. The microorganic nature of DGBIs resulting from systemic, metabolic or motility disorders, gut dysbiosis and inflammation are not addressed in the Rome IV criteria. Although there is a multidimensional clinical profile that does address these factors, it is not followed rigorously in practice. Threshold changes for diagnostic criteria or addition/deletion of symptoms leads to wide variation among different DGBI criteria resulting in uncertain comparability of results. Although the Rome IV criteria are excellent for research studies and therapeutic trials in homogenous populations, further improvement is needed for their wider applicability in clinical practice.
目前,根据罗马 IV 标准,肠-脑相互作用障碍(DGBIs)被分类为相互排斥的解剖区域相关基于症状的类别。内脏痛觉的病理生理学是导致 DGBIs 广泛症状的原因,涉及到来自肠道和大脑水平的多个系统的双向相互作用所产生的复杂心理生物学过程,这些过程影响症状的表达和疾病行为。对疾病的态度以及疼痛和肠道习惯的表达因文化而异,基于社会文化信仰的不同解释可能与医学定义不一致。因此,心理因素影响 DGBI 的定义、其严重程度和医疗保健利用。由于内脏疼痛的定位差和多节段牵涉,疼痛的解剖部位可能与受影响的节段不一致,并且症状之间可能存在不同程度的重叠。罗马 IV 标准有些限制地假设症状与潜在病理生理学之间存在一对一的相关性,而忽略了重叠的 DGBIs、非标准化的症状类别以及随着时间的推移类别发生的变化或转移。由于系统性、代谢性或运动障碍、肠道菌群失调和炎症导致的 DGBIs 的微生物性质在罗马 IV 标准中没有得到解决。尽管有一个多维的临床特征确实可以解决这些因素,但在实践中并没有严格遵循。诊断标准的阈值变化或症状的添加/删除导致不同 DGBI 标准之间存在广泛的差异,从而导致结果的可比性不确定。尽管罗马 IV 标准非常适合同质人群的研究和治疗试验,但在更广泛的临床实践中应用还需要进一步改进。
Clin Gastroenterol Hepatol. 2022-5
Gut Microbes. 2024
Nat Rev Gastroenterol Hepatol. 2025-4
United European Gastroenterol J. 2024-9
Neurogastroenterol Motil. 2025-2
Indian J Gastroenterol. 2025-7-2
Front Neurosci. 2025-1-13
Aliment Pharmacol Ther. 2025-1
J Gastroenterol Hepatol. 2023-2
Neurogastroenterol Motil. 2023-2
J Gastrointestin Liver Dis. 2022-9-15
Brain Imaging Behav. 2022-8